Mylan has announced that the United States District Court for the Northern District of West Virginia granted a Mylan motion for partial summary judgment and found that Teva’s generic formoterol fumarate inhalation solution infringes US Patent No. 6,667,344 on Mylan’s Perforomist inhalation solution. The court will hear arguments on other issues in the case later this month, the company said.
Earlier this month, the US District Court for the Southern District of New York ruled that Sunovion’s Brovana inhalation solution infringed on Mylan Perforomist patents. Mylan and Sunovion settled that suit in May 2012.
Read the Mylan press release.
